Get access

CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity

Authors


Dr S. Brian Wilson
Diabetes Research Laboratories
65 Landsdowne Street
Cambridge
MA 02139
USA
Tel: +1 617 768 8883
Fax: +1 617 768 8888
e-mail: brian_wilson@dfci.harvard.edu

Abstract

Abstract:  CD1d-restricted T-cells are activated by glycolipids presented by the major histocompatibility complex class-Ib molecule CD1d, found on the surface of antigen-presenting cells (APC). This interaction between APC, most notably dendritic cells (DC), and CD1d-restricted T-cells is an important regulatory step in the initiation of adaptive immune responses. It is well known that DC play a crucial role in the induction of contact hypersensitivity (CHS), a frequently studied form of in vivo T-cell-mediated immunity. In this study, we show that CD1d-restricted T-cells are also necessary for CHS, because both wild-type mice treated systemically or topically with CD1d glycolipid antagonists and CD1d-restricted T-cell-null mice have markedly diminished CHS responses. Thus, pharmacologic antagonists of CD1d can be used as effective inhibitors of CHS, a prototype for a variety of delayed-type tissue hypersensitivity responses.

Ancillary